Superior cervical ganglion-10 protein as a molecular effector of c-Jun N-terminal kinase 1: implications for the therapeutic targeting of Jun N-terminal kinase in nerve regeneration.
BACKGROUND
Cell stress and tissue injury lead to c-Jun N-terminal kinase (JNK) activation, which is known to contribute to cell death. Paradoxically, strong evidence supports an important role for JNK in the regeneration of neuronal processes, subsequent to injury.


OBJECTIVE
Recent research revealed the growth cone-associated protein superior cervical ganglion-10 protein as a candidate effector for the regeneration pathway mediated by JNK1. This implies that neuroprotective strategies targeting JNK may have negative effects on neuronal regeneration, unless JNK1 function is spared, and that the mechanistic relationships between JNK1 and neuronal regeneration deserve increased attention.


RESULTS
This review proposes a model reconciling the microtubule regulatory properties of superior cervical ganglion protein 10 with its role as a JNK effector of regeneration and highlight remaining issues to be resolved.
Westerlund
Nina
N
University of Turku and Abo Akademi University, Turku Centre for Biotechnology, BioCity, Tykistokatu 6, Turku FIN-20521, Finland.
Zdrojewska
Justyna
J
Courtney
Michael J
MJ
Coffey
Eleanor T
ET
D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics / Q000502:physiology*; D008870:Microtubules / Q000378:metabolism; D048055:Mitogen-Activated Protein Kinase 8 / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D009416:Nerve Regeneration / Q000502:physiology*; D050777:Stathmin; D017783:Superior Cervical Ganglion / Q000378:metabolism*
D008565:Membrane Proteins; C063314:STMN2 protein, human; D050777:Stathmin; D048055:Mitogen-Activated Protein Kinase 8